ArticleFrontiers in pharmacology2023

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension.

Wenxing Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.